Seeing The Early Signs: Dementia Detection in Women

Women represent nearly two-thirds of people living with Alzheimer’s disease worldwide. While longer life expectancy plays a role, emerging research suggests that biological, hormonal, and social factors may also influence both risk and symptom presentation.

For women in particular, early signs of dementia are frequently missed or dismissed, delaying diagnosis and support.

 

Why Early Signs in Women Are Often Overlooked

Early symptoms of dementia in women can be subtle and may differ slightly from traditional expectations. Memory loss is often emphasized, but the earliest indicators are not always about forgetting.

Women may initially experience:

• Changes in attention or concentration
• Difficulty multitasking or organizing daily tasks
• Increased mental fatigue
• Subtle language difficulties, such as trouble finding words
• Mood changes, including anxiety, irritability, or withdrawal

 

These symptoms are often attributed to menopause, stress, or caregiving responsibilities – roles many women hold throughout their lives. As a result, concerns may be minimized or normalized rather than investigated.

 

The Role of Hormones and Brain Health

Recent research has explored the connection between estrogen and brain function. Estrogen plays a role in memory, neural communication, and protection against inflammation. During menopause, estrogen levels decline significantly, which may contribute to changes in cognition.

Some studies suggest that this hormonal transition could make the brain more vulnerable to neurodegenerative processes, particularly when combined with other risk factors such as genetics, cardiovascular health, and lifestyle.

However, it is important to recognize that not all cognitive changes during midlife indicate dementia. The key difference lies in persistence and progression. Early dementia-related changes tend to worsen over time and interfere with daily functioning.

 

Behavioural Clues: Looking Beyond Memory

In dementia care, behaviour is communication. Early signs in women may present as changes in personality or daily habits rather than obvious cognitive decline.

Caregivers and loved ones might notice:

• Increased difficulty managing finances or medications
• Withdrawal from social activities once enjoyed
• Repeating questions or stories more frequently
• Trouble following conversations
• Reduced confidence in decision-making

 

These shifts may be gradual. A person may compensate well at first, masking symptoms until challenges become more noticeable.

 

The Importance of Listening and Observing

Women are often highly skilled at adapting and maintaining routines, even when experiencing cognitive changes. This ability can delay detection. For this reason, listening carefully to concerns – both from the individual and those close to them- is critical.

Statements like, “I just don’t feel like myself,” or “I’m more forgetful than usual,” should not be dismissed, especially if they persist or worsen.

Early medical assessment may include:

• cognitive screening; 
• review of medical history; and, when appropriate, 
• imaging or biomarker testing. 

 

These tools are becoming increasingly refined, allowing for more accurate and earlier diagnosis.

 

Clinical Assessment and Cognitive Testing

When dementia is suspected, a healthcare provider will typically begin with a comprehensive clinical assessment that includes:

• Detailed medical and family history
• Review of medications and chronic health conditions
• Assessment of mood, sleep, and stress levels
• Standardized cognitive screening tools (e.g., MoCA or MMSE)
• Functional evaluation of daily living activities

 

However, research shows that standard cognitive tests may be less sensitive in early-stage dementia in women, particularly because women often perform better on verbal memory tasks in the early phases of disease progression. This can lead to underestimation of impairment if testing is not interpreted carefully within the clinical context.

 

The Role of Biomarkers and Brain Imaging

Advances in diagnostic science are improving early detection accuracy, especially in cases where symptoms are unclear.

Common tools include:

• Blood-based biomarkers (such as phosphorylated tau and beta-amyloid), which may detect pathological changes years before symptoms become severe
• Cerebrospinal fluid (CSF) testing, which measures proteins associated with Alzheimer’s disease
• Brain imaging (MRI and PET scans), which can identify structural changes, reduced brain volume, or amyloid accumulation

 

Recent research highlights that women may show different biomarker patterns compared to men, including stronger associations between genetic risk factors (such as APOE ε4) and disease progression. 

These differences are increasingly informing sex-specific diagnostic approaches; that is, doctors and researchers are learning that men and women can show signs of dementia differently, so they are starting to use different or adjusted ways to detect and diagnose it depending on sex.

 

A Compassionate Approach to Awareness

Early detection is not about creating fear; rather, it is about creating awareness. It is about recognizing that subtle changes matter and that seeking answers is an act of care, not alarm.

For women, whose symptoms may be overlooked or misunderstood, this awareness is especially important. 

In dementia care, small observations can lead to significant impact. When we notice early changes and take them seriously, we open the door to understanding, support, and dignity throughout the journey.

 

References:

1. Alzheimer’s Association. (2024). 2024 Alzheimer’s disease facts and figures. https://www.alz.org/alzheimers-dementia/facts-figures
2. Buckley, R. F., Mormino, E. C., Amariglio, R. E., Properzi, M. J., Rabin, J. S., Lim, Y. Y., Papp, K. V., Jacobs, H. I. L., Burnham, S., Hanseeuw, B. J., Doré, V., Dobson, A., Masters, C. L., Waller, M., Rowe, C. C., Maruff, P., Donohue, M. C., Rentz, D. M., Johnson, K. A., … Sperling, R. A. (2018). Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer’s disease: Findings from three well-characterized cohorts. Alzheimer’s & Dementia, 14(9), 1193–1203. https://pubmed.ncbi.nlm.nih.gov/29803541/
3. Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., Giacobini, E., Depypere, H., & Hampel, H. (2018). Sex differences in Alzheimer disease: The gateway to precision medicine. Nature Reviews Neurology, 14(8), 457–469. https://doi.org/10.1038/s41582-018-0032-9
4. Garg, R., & Munshi, A. (2025). Beyond hot flashes: The role of estrogen receptors in menopausal mental health and cognitive decline. Journal of Mid-Life Health, 16(1), 1–10. https://pmc.ncbi.nlm.nih.gov/articles/PMC12469143/
5. Mosconi, L., Rahman, A., Diaz, I., Wu, X., Scheyer, O., Hristov, H., Vallabhajosula, S., Isaacson, R. S., & Brinton, R. D. (2021). Menopause impacts human brain structure, connectivity, and energy metabolism. Scientific Reports, 11, 10867. https://www.nature.com/articles/s41598-021-90084-y
6. Emrani, S., & Sundermann, E. E. (2025). Sex/gender differences in the clinical trajectory of Alzheimer’s disease: Insights into diagnosis and cognitive reserve. Frontiers in Neuroendocrinology, 77, 101184. https://doi.org/10.1016/j.yfrne.2025.101184
7. Williams, S. (2026, April 1). Women get Alzheimer’s more often than men: Five things the science tells us. Stanford Medicine. https://med.stanford.edu/news/insights/2026/04/women-alzheimers.html
8. Why are women more likely to develop Alzheimer’s disease? (2022, January 20). Harvard Health Publishing. https://www.health.harvard.edu/blog/why-are-women-more-likely-to-develop-alzheimers-disease-20220120267

 

At Dementia Solutions, we’ve made it our mission to demystify dementia behaviour and continue to explore person-centred, creative, non-pharmacological solutions to manage dementia-related behaviours. We believe that awareness creation and skill-building through education is the most effective and powerful tool we have to promote and maintain the well-being of both the person with dementia and their caregiver.